Asthma Patients Skipping Doses Owing to High Cost
Out-of-pocket costs are preventing many people from taking vital
asthma medication, says a new study, calling for urgent interventions to
promote discussions between patients and doctors about the cost of
medicines to treat asthma.
The most commonly prescribed preventer treatments for asthma contain inhaled corticosteroids (ICS) which, if taken regularly, reduce the severity of the disease and the number of asthma-related deaths, said the researchers.
According to reports, at least one in every 10 asthma patient globally lives in India and the economic costs associated with asthma exceed those of TB and HIV/AIDS combined.
To reach this conclusion, researchers surveyed 1,400 people with asthma in Australia and found that half of the adults and one-third of the children in the study were either decreasing or skipping doses of asthma medicines to make them last longer.
"We know that preventer inhalers can be incredibly effective at controlling symptoms and preventing people from being hospitalised or even from dying of asthma, yet our study has found that out-of-pocket costs are preventing many from accessing medicines which can be life-saving," said senior research.
The study found that young male adults were the most likely to under-use asthma treatments.
This was compounded by doctors being largely unaware that out-of-pocket costs were a significant concern for many of their patients, or that some preventers had lower out-of-pocket costs for patients than others.
According to fellow study author, asthma is a long-term disease and one where people really need to keep the inflammation under control by taking a preventative medicine and not just relying on short-term symptom relief from a blue inhaler.
"We need doctors to talk to their patients to stress that this Band-Aid approach does not work, and can leave them hospitalised or even worse as a result," said the author.
The most commonly prescribed preventer treatments for asthma contain inhaled corticosteroids (ICS) which, if taken regularly, reduce the severity of the disease and the number of asthma-related deaths, said the researchers.
According to reports, at least one in every 10 asthma patient globally lives in India and the economic costs associated with asthma exceed those of TB and HIV/AIDS combined.
To reach this conclusion, researchers surveyed 1,400 people with asthma in Australia and found that half of the adults and one-third of the children in the study were either decreasing or skipping doses of asthma medicines to make them last longer.
"We know that preventer inhalers can be incredibly effective at controlling symptoms and preventing people from being hospitalised or even from dying of asthma, yet our study has found that out-of-pocket costs are preventing many from accessing medicines which can be life-saving," said senior research.
The study found that young male adults were the most likely to under-use asthma treatments.
This was compounded by doctors being largely unaware that out-of-pocket costs were a significant concern for many of their patients, or that some preventers had lower out-of-pocket costs for patients than others.
According to fellow study author, asthma is a long-term disease and one where people really need to keep the inflammation under control by taking a preventative medicine and not just relying on short-term symptom relief from a blue inhaler.
"We need doctors to talk to their patients to stress that this Band-Aid approach does not work, and can leave them hospitalised or even worse as a result," said the author.
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE
HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.
PS-
THOSE INTERESTED IN
RECIPES ARE FREE TO VIEW MY BLOG-
https://gseasyrecipes.blogspot.com/
FOR INFO ABOUT KNEE
REPLACEMENT, YOU CAN VIEW MY BLOG-
https:// kneereplacement-stickclub.blogspot.com/
FOR
CROCHET DESIGNS
https://gscrochetdesigns.blogspot.com
Labels: asthma drugs, inexpensive, inflammation, inhaled corticosteroids, long-term
0 Comments:
Post a Comment
<< Home